-
Je něco špatně v tomto záznamu ?
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them
C. Garbe, AM. Forsea, T. Amaral, P. Arenberger, P. Autier, M. Berwick, B. Boonen, M. Bylaite, V. Del Marmol, B. Dreno, MC. Fargnoli, AC. Geller, AC. Green, R. Greinert, A. Hauschild, CA. Harwood, I. Hoorens, L. Kandolf, R. Kaufmann, N....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
- MeSH
- lidé MeSH
- melanom prevence a kontrola etiologie epidemiologie MeSH
- nádory kůže * prevence a kontrola etiologie epidemiologie MeSH
- nádory vyvolané zářením prevence a kontrola etiologie epidemiologie MeSH
- pigmentace kůže účinky záření MeSH
- přípravky chránící proti slunci terapeutické užití MeSH
- rizikové faktory MeSH
- ultrafialové záření * škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Cancers of the skin are the most commonly occurring cancers in humans. In fair-skinned populations, up to 95% of keratinocyte skin cancers and 70-95% of cutaneous melanomas are caused by ultraviolet radiation and are thus theoretically preventable. Currently, however, there is no comprehensive global advice on practical steps to be taken to reduce the toll of skin cancer. To address this gap, an expert working group comprising clinicians and researchers from Africa, America, Asia, Australia, and Europe, together with learned societies (European Association of Dermato-Oncology, Euromelanoma, Euroskin, European Union of Medical Specialists, and the Melanoma World Society) reviewed the extant evidence and issued the following evidence-based recommendations for photoprotection as a strategy to prevent skin cancer. Fair skinned people, especially children, should minimise their exposure to ultraviolet radiation, and are advised to use protective measures when the UV index is forecast to reach 3 or higher. Protective measures include a combination of seeking shade, physical protection (e.g. clothing, hat, sunglasses), and applying broad-spectrum, SPF 30 + sunscreens to uncovered skin. Intentional exposure to solar ultraviolet radiation for the purpose of sunbathing and tanning is considered an unhealthy behaviour and should be avoided. Similarly, use of solaria and other artificial sources of ultraviolet radiation to encourage tanning should be strongly discouraged, through regulation if necessary. Primary prevention of skin cancer has a positive return on investment. We encourage policymakers to communicate these messages to the general public and promote their wider implementation.
Azienda Unità Sanitaria Locale IRCCS di Reggio Emilia Skin Cancer Centre Reggio Emilia Italy
Belgian Cancer foundation Brussels Belgium
Brown University and 5 A Medical Centre Providence RI USA
Centre for Dermatooncology Department of Dermatology Eberhard Karls University Tuebingen Germany
Department of Dermatology Erasme Hospital Université Libre de Bruxelles Brussels Belgium
Department of Dermatology Faculty of Medicine Military Medical Academy Belgrade Serbia
Department of Dermatology Ghent University Hospital Ghent Belgium
Department of Dermatology Henry Ford Health Detroit MI USA
Department of Dermatology Maastricht UMC Comprehensive Cancer Centre Maastricht the Netherlands
Department of Dermatology Ruhr University Bochum Bochum Germany
Department of Dermatology Sapporo Medical University Sapporo Japan
Department of Dermatology University Hospital Schleswig Holstein Campus Kiel Kiel Germany
Department of Dermatology University of Modena and Reggio Emilia Modena Italy
Department of Dermatology Venerology and Allergology Frankfurt University Hospital Frankfurt Germany
Department of Medical Oncology Gustave Roussy and Paris Saclay University Villejuif France
Department of Social and Behavioural Sciences Public Health Campus Boston MA USA
France Nantes University Inserm 1302 INCIT F 44000 Nantes France
INSERM U976 Saint Louis Hospital Paris France
International Prevention Research Institute Dardilly France
Medical and Surgical Dermatology Service Hospital Universitario Virgen Macarena Sevilla Spain
Population Health Department QIMR Berghofer Medical Research Institute Brisbane QLD Australia
Private Practice Cape Town South Africa
Skin Cancer Centre Laboratory for Molecular Cell Biology Elbe Hospital Buxtehude Buxtehude Germany
Université Paris Cite AP HP Dermato oncology and CIC Cancer institute APHP Nord Paris Cité France
University of New Mexico Comprehensive Cancer Centre Albuquerque USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013659
- 003
- CZ-PrNML
- 005
- 20240905134009.0
- 007
- ta
- 008
- 240725e20240424enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejca.2024.114074 $2 doi
- 035 __
- $a (PubMed)38691877
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Garbe, Claus $u Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address: claus.garbe@med.uni-tuebingen.de
- 245 10
- $a Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them / $c C. Garbe, AM. Forsea, T. Amaral, P. Arenberger, P. Autier, M. Berwick, B. Boonen, M. Bylaite, V. Del Marmol, B. Dreno, MC. Fargnoli, AC. Geller, AC. Green, R. Greinert, A. Hauschild, CA. Harwood, I. Hoorens, L. Kandolf, R. Kaufmann, N. Kelleners-Smeets, A. Lallas, C. Lebbé, U. Leiter, HW. Lim, C. Longo, J. Malvehy, D. Moreno, G. Pellacani, K. Peris, C. Robert, P. Saiag, D. Schadendorf, H. Peter Soyer, E. Stockfleth, A. Stratigos, H. Uhara, R. Vieira, B. Volkmer, MA. Weinstock, D. Whitaker, I. Zalaudek, DC. Whiteman, L. Brochez
- 520 9_
- $a Cancers of the skin are the most commonly occurring cancers in humans. In fair-skinned populations, up to 95% of keratinocyte skin cancers and 70-95% of cutaneous melanomas are caused by ultraviolet radiation and are thus theoretically preventable. Currently, however, there is no comprehensive global advice on practical steps to be taken to reduce the toll of skin cancer. To address this gap, an expert working group comprising clinicians and researchers from Africa, America, Asia, Australia, and Europe, together with learned societies (European Association of Dermato-Oncology, Euromelanoma, Euroskin, European Union of Medical Specialists, and the Melanoma World Society) reviewed the extant evidence and issued the following evidence-based recommendations for photoprotection as a strategy to prevent skin cancer. Fair skinned people, especially children, should minimise their exposure to ultraviolet radiation, and are advised to use protective measures when the UV index is forecast to reach 3 or higher. Protective measures include a combination of seeking shade, physical protection (e.g. clothing, hat, sunglasses), and applying broad-spectrum, SPF 30 + sunscreens to uncovered skin. Intentional exposure to solar ultraviolet radiation for the purpose of sunbathing and tanning is considered an unhealthy behaviour and should be avoided. Similarly, use of solaria and other artificial sources of ultraviolet radiation to encourage tanning should be strongly discouraged, through regulation if necessary. Primary prevention of skin cancer has a positive return on investment. We encourage policymakers to communicate these messages to the general public and promote their wider implementation.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory kůže $x prevence a kontrola $x etiologie $x epidemiologie $7 D012878
- 650 12
- $a ultrafialové záření $x škodlivé účinky $7 D014466
- 650 _2
- $a pigmentace kůže $x účinky záření $7 D012880
- 650 _2
- $a přípravky chránící proti slunci $x terapeutické užití $7 D013473
- 650 _2
- $a melanom $x prevence a kontrola $x etiologie $x epidemiologie $7 D008545
- 650 _2
- $a nádory vyvolané zářením $x prevence a kontrola $x etiologie $x epidemiologie $7 D009381
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Forsea, Ana-Maria $u Dermatology Department, Elias University Hospital, Carol Davila University of Medicine and Pharmacy Bucharest, Romania
- 700 1_
- $a Amaral, Teresa $u Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany
- 700 1_
- $a Arenberger, Petr $u Department of Dermatovenereology, Charles University Third Medical Faculty and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Autier, Philippe $u International Prevention Research Institute (i-PRI), Dardilly, France
- 700 1_
- $a Berwick, Marianne $u University of New Mexico Comprehensive Cancer Centre, Albuquerque, USA
- 700 1_
- $a Boonen, Brigitta $u Belgian Cancer foundation, Brussels, Belgium
- 700 1_
- $a Bylaite, Matilda $u Faculty of Medicine, Centre of Dermatovenereology, Clinic of Infectious Diseases and Dermatovenereology, Vilnius University, Vilnius, Lithuania
- 700 1_
- $a Del Marmol, Veronique $u Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- 700 1_
- $a Dreno, Brigitte $u France Nantes University, Inserm 1302, INCIT, F-44000 Nantes, France
- 700 1_
- $a Fargnoli, Maria Concetta $u Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy
- 700 1_
- $a Geller, Alan C $u Department of Social and Behavioural Sciences, Public Health Campus, Boston, MA, USA
- 700 1_
- $a Green, Adele C $u Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
- 700 1_
- $a Greinert, Rüdiger $u Skin Cancer Centre, Laboratory for Molecular Cell Biology, Elbe Hospital Buxtehude, Buxtehude, Germany
- 700 1_
- $a Hauschild, Axel $u Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany
- 700 1_
- $a Harwood, Catherine A $u Department of Dermatology, Barts Health NHS Trust and Centre for Cell Biology and Cutaneous Research Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK
- 700 1_
- $a Hoorens, Isabelle $u Department of Dermatology, Ghent University Hospital, Ghent, Belgium
- 700 1_
- $a Kandolf, Lidija $u Department of Dermatology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia
- 700 1_
- $a Kaufmann, Roland $u Department of Dermatology, Venerology and Allergology, Frankfurt University Hospital, Frankfurt, Germany
- 700 1_
- $a Kelleners-Smeets, Nicole $u GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Dermatology, Maastricht UMC+ Comprehensive Cancer Centre, Maastricht, the Netherlands
- 700 1_
- $a Lallas, Aimilios $u First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece
- 700 1_
- $a Lebbé, Celeste $u Université Paris Cite, AP-HP Dermato-oncology and CIC, Cancer institute APHP. Nord Paris Cité, France; INSERM U976, Saint Louis Hospital, Paris, France
- 700 1_
- $a Leiter, Ulrike $u Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany
- 700 1_
- $a Lim, Henry W $u Department of Dermatology, Henry Ford Health, Detroit, MI, USA
- 700 1_
- $a Longo, Caterina $u Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Centre, Reggio Emilia, Italy
- 700 1_
- $a Malvehy, Joseph $u Department of Dermatology, Hospital Clínic de Barcelona (Melanoma Unit), University of Barcelona, IDIBAPS, Barcelona & CIBERER, Barcelona, Spain
- 700 1_
- $a Moreno, David $u Medical-&-Surgical Dermatology Service. Hospital Universitario Virgen Macarena, Sevilla, Spain
- 700 1_
- $a Pellacani, Giovanni $u Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy
- 700 1_
- $a Peris, Ketty $u Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy; UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy
- 700 1_
- $a Robert, Caroline $u Department of Medical Oncology, Gustave Roussy and Paris Saclay University, Villejuif, France
- 700 1_
- $a Saiag, Philippe $u Department of General and Oncologic Dermatology, Ambroise Paré hospital, APHP, & EA 4340 "Biomarkers in cancerology and haematooncology", UVSQ, Université Paris-Saclay, 92104 Boulogne-Billancourt, France
- 700 1_
- $a Schadendorf, Dirk $u Department of Dermatology & West German Cancer Centre, University Hospital Essen & German Cancer Consortium, Campus Essen & National Centre for tumour Diseases (NCT)-West, Campus Essen, Germany
- 700 1_
- $a Peter Soyer, H $u Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia
- 700 1_
- $a Stockfleth, Eggert $u Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
- 700 1_
- $a Stratigos, Alex $u First Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece
- 700 1_
- $a Uhara, Hisashi $u Department of Dermatology, Sapporo Medical University, Sapporo, Japan
- 700 1_
- $a Vieira, Ricardo $u Department of Dermatology and Venereology, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal
- 700 1_
- $a Volkmer, Beate $u Skin Cancer Centre, Laboratory for Molecular Cell Biology, Elbe Hospital Buxtehude, Buxtehude, Germany
- 700 1_
- $a Weinstock, Martin A $u Brown University and V A Medical Centre, Providence, RI, USA
- 700 1_
- $a Whitaker, Dagmar $u Private Practice, Cape Town, South Africa
- 700 1_
- $a Zalaudek, Iris $u Department of Dermatology and Venereology of the Hospital Clinics Giuliano Isontino (ASUGI), Maggiore Hospital, Trieste, Italy
- 700 1_
- $a Whiteman, David C $u Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
- 700 1_
- $a Brochez, Lieve $u Department of Dermatology, Ghent University Hospital, Ghent, Belgium
- 773 0_
- $w MED00009626 $t European journal of cancer $x 1879-0852 $g Roč. 204 (20240424), s. 114074
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38691877 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134002 $b ABA008
- 999 __
- $a ok $b bmc $g 2143449 $s 1225525
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 204 $c - $d 114074 $e 20240424 $i 1879-0852 $m European journal of cancer $n Eur J Cancer $x MED00009626
- LZP __
- $a Pubmed-20240725
